Stefania Stefani
Overview
Explore the profile of Stefania Stefani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
204
Citations
3381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boattini M, Bianco G, Bastos P, Mavromanolaki V, Maraki S, Spiliopoulou A, et al.
Int J Antimicrob Agents
. 2025 Mar;
:107478.
PMID: 40024606
Introduction: Despite being implicated in a wide spectrum of community- and healthcare-acquired infections, anaerobes have not yet been incorporated into systematic surveillance programs in Europe. Methods: We conducted a multicentre...
2.
Bonomo C, Mannino E, Bongiorno D, Vocale C, Amicucci A, Bivona D, et al.
Pathogens
. 2025 Feb;
14(2).
PMID: 40005528
(Group A Streptococcus, GAS) is a Gram-positive pathogen responsible for both superficial and invasive infections (iGAS), with increasing global incidence in recent years. This study aims to characterize the molecular...
3.
Nicitra E, Terrana M, Bongiorno D, Dodaro S, Greco F, Greco S, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001372
Carbapenem-resistant has become endemic in Europe, including in Italy, where its prevalence has risen dramatically, primarily due to epidemic clones harboring metallo-enzymes. This study aims to investigate the dissemination of...
4.
Maugeri G, Calvo M, Bongiorno D, Bivona D, Migliorisi G, Privitera G, et al.
Microorganisms
. 2025 Jan;
13(1).
PMID: 39858857
represent a common invasive infection etiological agent, whose potential carbapenem-resistance and hypermucoviscosity complicate the patient's management. Infection development often derives from gastrointestinal colonization; thus, it is fundamental to monitor asymptomatic...
5.
Stefani S, Piccioni G, Poulet F, Filacchione G, Vincendon M, Barbis A, et al.
Rev Sci Instrum
. 2025 Jan;
96(1.
PMID: 39841069
No abstract available.
6.
Fasciana T, Antonelli A, Bianco G, Lombardo D, Codda G, Roscetto E, et al.
Epidemiol Prev
. 2024 Dec;
48(6):470-475.
PMID: 39679488
Carbapenem-resistant Enterobacterales (CREs) are globally considered to be a major threat to public health. National and international guidelines emphasize the importance of routine active surveillance policies to prevent their transmission....
7.
Aluisio G, Mezzatesta M, Cafiso V, Scuderi R, Stefani S, Santagati M
Front Cell Infect Microbiol
. 2024 Dec;
14:1471107.
PMID: 39628665
Background: The use of beneficial bacteria like spp. is a potential innovative approach to fight antibiotic-resistant pathogens. is one of the most concerning multi drug-resistant (MDR) pathogens, and its ability...
8.
Chiappini E, Simeone G, Bergamini M, Pellegrino R, Guarino A, Staiano A, et al.
Ital J Pediatr
. 2024 Nov;
50(1):235.
PMID: 39501298
Sore throat represents one of the main causes of antibiotic overprescription in children. Its management is still a matter of debate, with countries considering streptococcal pharyngotonsillitis a benign and self-limiting...
9.
Virzi N, Greco V, Stracquadanio S, Jasim A, Greish K, Diaz-Rodriguez P, et al.
RSC Adv
. 2024 Oct;
14(46):34066-34080.
PMID: 39469023
The global spread of multi-drug-resistant (MDR) bacteria is rapidly increasing due to antibiotic overuse, posing a major public health threat and causing millions of deaths annually. The present study explored...
10.
Stracquadanio S, Stefani S
Int J Antimicrob Agents
. 2024 Oct;
64(6):107364.
PMID: 39455016
No abstract available.